(17Z,20Z,23Z,26Z,29Z,32Z,35Z,38Z,41Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetracosa-4,8-dien-2-yl]tetratetraconta-17,20,23,26,29,32,35,38,41-nonaenamide

C80H135NO13 — CID 165305921

IUPAC(17Z,20Z,23Z,26Z,29Z,32Z,35Z,38Z,41Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetracosa-4,8-dien-2-yl]tetratetraconta-17,20,23,26,29,32,35,38,41-nonaenamide
SMILESCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCCCCCCCCCCCC(=O)NC(COC1OC(CO)C(OC2OC(CO)C(O)C(O)C2O)C(O)C1O)C(O)/C=C/CC/C=C/CCCCCCCCCCCCCCC
InChIInChI=1S/C80H135NO13/c1-3-5-7-9-11-13-15-17-19-21-23-24-25-26-27-28-29-30-31-32-33-34-35-36-37-38-39-40-41-42-43-44-46-48-50-52-54-56-58-60-62-64-72(85)81-68(69(84)63-61-59-57-55-53-51-49-47-45-22-20-18-16-14-12-10-8-6-4-2)67-91-79-77(90)75(88)78(71(66-83)93-79)94-80-76(89)74(87)73(86)70(65-82)92-80/h5,7,11,13,17,19,23-24,26-27,29-30,32-33,35-36,38-39,53,55,61,63,68-71,73-80,82-84,86-90H,3-4,6,8-10,12,14-16,18,20-22,25,28,31,34,37,40-52,54,56-60,62,64-67H2,1-2H3,(H,81,85)/b7-5-,13-11-,19-17-,24-23-,27-26-,30-29-,33-32-,36-35-,39-38-,55-53+,63-61+
InChIKeyUWWGRMZXWLFTQU-ZGSVPSJZSA-N
MW1318.95 g/mol
LogP16.23
Rot. Bonds60

About (17Z,20Z,23Z,26Z,29Z,32Z,35Z,38Z,41Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetracosa-4,8-dien-2-yl]tetratetraconta-17,20,23,26,29,32,35,38,41-nonaenamide

(17Z,20Z,23Z,26Z,29Z,32Z,35Z,38Z,41Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetracosa-4,8-dien-2-yl]tetratetraconta-17,20,23,26,29,32,35,38,41-nonaenamide (PubChem CID 165305921) has the molecular formula C80H135NO13 and a molecular weight of 1318.95 g/mol. Its IUPAC name is (17Z,20Z,23Z,26Z,29Z,32Z,35Z,38Z,41Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetracosa-4,8-dien-2-yl]tetratetraconta-17,20,23,26,29,32,35,38,41-nonaenamide.

Molecular Properties

Compound Name(17Z,20Z,23Z,26Z,29Z,32Z,35Z,38Z,41Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetracosa-4,8-dien-2-yl]tetratetraconta-17,20,23,26,29,32,35,38,41-nonaenamide
PubChem CID165305921
Molecular FormulaC80H135NO13
Molecular Weight1318.95 g/mol
Exact Mass1317.99
IUPAC Name(17Z,20Z,23Z,26Z,29Z,32Z,35Z,38Z,41Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetracosa-4,8-dien-2-yl]tetratetraconta-17,20,23,26,29,32,35,38,41-nonaenamide
SMILESCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCCCCCCCCCCCC(=O)NC(COC1OC(CO)C(OC2OC(CO)C(O)C(O)C2O)C(O)C1O)C(O)/C=C/CC/C=C/CCCCCCCCCCCCCCC
InChIInChI=1S/C80H135NO13/c1-3-5-7-9-11-13-15-17-19-21-23-24-25-26-27-28-29-30-31-32-33-34-35-36-37-38-39-40-41-42-43-44-46-48-50-52-54-56-58-60-62-64-72(85)81-68(69(84)63-61-59-57-55-53-51-49-47-45-22-20-18-16-14-12-10-8-6-4-2)67-91-79-77(90)75(88)78(71(66-83)93-79)94-80-76(89)74(87)73(86)70(65-82)92-80/h5,7,11,13,17,19,23-24,26-27,29-30,32-33,35-36,38-39,53,55,61,63,68-71,73-80,82-84,86-90H,3-4,6,8-10,12,14-16,18,20-22,25,28,31,34,37,40-52,54,56-60,62,64-67H2,1-2H3,(H,81,85)/b7-5-,13-11-,19-17-,24-23-,27-26-,30-29-,33-32-,36-35-,39-38-,55-53+,63-61+
InChIKeyUWWGRMZXWLFTQU-ZGSVPSJZSA-N
XLogP16.23
TPSA227.86 Ų
H-Bond Donors9
H-Bond Acceptors13
Rotatable Bonds60
Heavy Atoms94
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001318.95
LogP ≤ 516.23
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (17Z,20Z,23Z,26Z,29Z,32Z,35Z,38Z,41Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetracosa-4,8-dien-2-yl]tetratetraconta-17,20,23,26,29,32,35,38,41-nonaenamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (17Z,20Z,23Z,26Z,29Z,32Z,35Z,38Z,41Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetracosa-4,8-dien-2-yl]tetratetraconta-17,20,23,26,29,32,35,38,41-nonaenamide?
The IUPAC name of (17Z,20Z,23Z,26Z,29Z,32Z,35Z,38Z,41Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetracosa-4,8-dien-2-yl]tetratetraconta-17,20,23,26,29,32,35,38,41-nonaenamide (CID 165305921) is (17Z,20Z,23Z,26Z,29Z,32Z,35Z,38Z,41Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetracosa-4,8-dien-2-yl]tetratetraconta-17,20,23,26,29,32,35,38,41-nonaenamide.
What is the SMILES notation for (17Z,20Z,23Z,26Z,29Z,32Z,35Z,38Z,41Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetracosa-4,8-dien-2-yl]tetratetraconta-17,20,23,26,29,32,35,38,41-nonaenamide?
The canonical SMILES for (17Z,20Z,23Z,26Z,29Z,32Z,35Z,38Z,41Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetracosa-4,8-dien-2-yl]tetratetraconta-17,20,23,26,29,32,35,38,41-nonaenamide is CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCCCCCCCCCCCC(=O)NC(COC1OC(CO)C(OC2OC(CO)C(O)C(O)C2O)C(O)C1O)C(O)/C=C/CC/C=C/CCCCCCCCCCCCCCC.
What is the InChIKey of (17Z,20Z,23Z,26Z,29Z,32Z,35Z,38Z,41Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetracosa-4,8-dien-2-yl]tetratetraconta-17,20,23,26,29,32,35,38,41-nonaenamide?
The InChIKey is UWWGRMZXWLFTQU-ZGSVPSJZSA-N. The full InChI is InChI=1S/C80H135NO13/c1-3-5-7-9-11-13-15-17-19-21-23-24-25-26-27-28-29-30-31-32-33-34-35-36-37-38-39-40-41-42-43-44-46-48-50-52-54-56-58-60-62-64-72(85)81-68(69(84)63-61-59-57-55-53-51-49-47-45-22-20-18-16-14-12-10-8-6-4-2)67-91-79-77(90)75(88)78(71(66-83)93-79)94-80-76(89)74(87)73(86)70(65-82)92-80/h5,7,11,13,17,19,23-24,26-27,29-30,32-33,35-36,38-39,53,55,61,63,68-71,73-80,82-84,86-90H,3-4,6,8-10,12,14-16,18,20-22,25,28,31,34,37,40-52,54,56-60,62,64-67H2,1-2H3,(H,81,85)/b7-5-,13-11-,19-17-,24-23-,27-26-,30-29-,33-32-,36-35-,39-38-,55-53+,63-61+.
What are the key properties of (17Z,20Z,23Z,26Z,29Z,32Z,35Z,38Z,41Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetracosa-4,8-dien-2-yl]tetratetraconta-17,20,23,26,29,32,35,38,41-nonaenamide?
(17Z,20Z,23Z,26Z,29Z,32Z,35Z,38Z,41Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetracosa-4,8-dien-2-yl]tetratetraconta-17,20,23,26,29,32,35,38,41-nonaenamide has a molecular weight of 1318.95 g/mol, XLogP of 16.23, 60 rotatable bonds, 9 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for (17Z,20Z,23Z,26Z,29Z,32Z,35Z,38Z,41Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetracosa-4,8-dien-2-yl]tetratetraconta-17,20,23,26,29,32,35,38,41-nonaenamide is sourced from PubChem (CID 165305921), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).